Shingles vaccine study for adults 40+
Treatments studied
Part of Infections clinical trials.
This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You must be generally healthy, or have stable chronic conditions like high blood pressure or diabetes that are well controlled.
- You cannot have a history of shingles or have ever received a shingles or chickenpox vaccine.
- You cannot have a weakened immune system or have been on long-term strong immune-suppressing medications in the last 6 months.
- You cannot have had a severe allergic reaction to a vaccine or medication before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
This trial tests an investigational vaccine called SYS6017 to see if it's safe and creates a good immune response. It is for healthy people age 40 and older who have never had shingles or the shingles vaccine.
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.
This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.
Hear when a new Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.